- Home
- MUX vs IGMS Comparison
MUX vs IGMS Comparison
Compare MUX & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- IGMS
- Stock Information
- Founded
- MUX 1979
- IGMS 1993
- Country
- MUX Canada
- IGMS United States
- Employees
- MUX N/A
- IGMS N/A
- Industry
- MUX Precious Metals
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- IGMS Health Care
- Exchange
- MUX Nasdaq
- IGMS Nasdaq
- Market Cap
- MUX 443.5M
- IGMS 528.6M
- IPO Year
- MUX N/A
- IGMS 2019
- Fundamental
- Price
- MUX $7.98
- IGMS $6.90
- Analyst Decision
- MUX Strong Buy
- IGMS Buy
- Analyst Count
- MUX 2
- IGMS 7
- Target Price
- MUX $15.63
- IGMS $17.43
- AVG Volume (30 Days)
- MUX 524.3K
- IGMS 219.5K
- Earning Date
- MUX 11-05-2024
- IGMS 11-08-2024
- Dividend Yield
- MUX N/A
- IGMS N/A
- EPS Growth
- MUX N/A
- IGMS N/A
- EPS
- MUX 2.07
- IGMS N/A
- Revenue
- MUX $199,634,000.00
- IGMS $2,918,000.00
- Revenue This Year
- MUX $22.76
- IGMS $386.95
- Revenue Next Year
- MUX $18.67
- IGMS N/A
- P/E Ratio
- MUX $3.86
- IGMS N/A
- Revenue Growth
- MUX 47.02
- IGMS 57.64
- 52 Week Low
- MUX $5.92
- IGMS $6.17
- 52 Week High
- MUX $12.50
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- MUX 40.50
- IGMS 29.48
- Support Level
- MUX $7.78
- IGMS $7.00
- Resistance Level
- MUX $8.45
- IGMS $10.80
- Average True Range (ATR)
- MUX 0.40
- IGMS 0.94
- MACD
- MUX -0.05
- IGMS -0.10
- Stochastic Oscillator
- MUX 13.33
- IGMS 2.98
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company focused on precious and base minerals in Argentina, Mexico, and the United States. The company's overall revenue is principally derived from the production of gold and silver. The company owns and operates the wholly-owned El Gallo 1 mine in Mexico, and has a minority shareholding in the company that operates the San Jose mine in Argentina. More than half the company's gold output is produced by the El Gallo 1 mine. The remaining gold production, and the majority of silver production, is produced by the San Jose mine. Geographically, the majority is from Canada.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.